In terms of Regulation 29 of Securities & Exchange Board of India (Listing Obligations and Disclosures) Regulations, 2015, Shamrock Industrial Co has informed that the Meeting of the Board of Directors of the company will be held on 25th June, 2022 on Saturday at the registered office of the Company at 03.00 pm to consider and approve the following: To confirm the appointment of Neeta Jitesh Khokhani (DIN: 08272554) Director, who retires by rotation and being eligible, offers herself for re-appointment at ensuing Annual General Meeting, To appoint new Statutory Auditors in place of R. Soni & Company who has completed their tenor and eligible to hold office till ensuing Annual General Meeting, To recommend to the members the confirmation of appointment of Dinesh Murlidhar Tiwari (DIN: 09566988) from Additional Director to Independent Director, To re-appoint Kamlesh Rameshchandra Khokhani (DIN: 00322223) as a Managing Director of the Company for next 5 years with effect from 22nd August, 2022, To Consider and fix day, date, time, venue and calendar of events in connection with 31st Annual General Meeting of the Company, To fix the dates for the closing of Register of Members and Transfer Books in connection with 31st Annual General Meeting of the Company, To appoint Scrutinizer for 31st Annual General Meeting of the Company, To adopt Directors Report for F.Y. 2021-22 and Notice for 31st Annual General Meeting; and any other items with the permission of Chairman.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1887.95 |
| Dr. Reddys Labs. | 1348.70 |
| Cipla | 1431.65 |
| Zydus Lifesciences | 1149.00 |
| Lupin | 2457.45 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: